Role of nitrates for the therapy of coronary-artery disease patients in the years beyond 2000

Journal of Cardiovascular Pharmacology

Volumn 34, Issue SUPPL. 2, 1999, Pages

  Darius, Harald ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Coronary artery disease; Heart failure; Myocardial infarction; Nitrovasodilators

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; NITRATE; VASODILATOR AGENT;

CONFERENCE PAPER; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG TOLERANCE; HEART AFTERLOAD; HEART FAILURE; HEART INFARCTION; HEART PRELOAD; HEART VENTRICLE FUNCTION; HOLTER MONITORING; PRIORITY JOURNAL; ST SEGMENT;

ANGINA PECTORIS; CLINICAL TRIALS; CORONARY DISEASE; DRUG TOLERANCE; FORECASTING; HUMANS; MYOCARDIAL INFARCTION; NITRATES; VASODILATOR AGENTS;

EID: 0032885593     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199908002-00004     Document Type: Conference Paper

References (25)

1. Davies RF, Goldberg D, Forman S, et al. Asymptomatic cardiac ischemia pilot (ACIP) study two year follow up. Outcomes of patients randomized to initial strategies of medical therapy versus revascularisation. Circulation 1997;95:2037-43.
2. Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998;338:1785-92.
3. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second randomized intervention treatment of angina (RITA-2) trial. Lancet 1997;350:461-8.
4. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Luscher TF. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998;97: 2494-8.
5. Parker JD, Parker JO. Nitrate therapy for stable anaina pectoris. N Engl J Med 1998:338:520-31.
6. Dubiel JP, Moczurad KW, Bryniarski L. Efficacy of a single dose of slow-release isosorbide dinitrate in the treatment of silent or painful myocardial ischemia in stable angina pectoris. Am J Cardiol 1992; 69:1156-60.
7. Willich SN, Lewis M, Löwel H, et al. Physical exertion as a trigger of acute myocardial infarction. N Engl J Med 1993;329:1684-90.
8. Hausmann D, Nikutta P, Daniel WG, Hartwig CA, Wenzlaff P, Lichtlen PR. Once-a-day administration of a high dose of ISDN (120 mg): influence on circadian variation of transient, reversible ischemic episodes in patients with stable angina pectoris. Ztschr Kardiol 1989:73:415-420.
9. Thadani U, Opie LH. Nitrate for unstable anaina. Cardiovasc Drugs Ther 1994;8:719-26
10. Thadani U. Secondary preventive potential of nitrates in ischemic heart disease. Eur Heart J 1996;17(suppl. F):30-6.
11. Rapaport E. Influence of long-acting nitrate therapy on the risk of reinfarction, sudden death, and total mortality in survivors of acute myocardial infarction. Am Heart J 1985;110:276-80.
12. ISIS-4 Collaborative Group. ISIS-4: a randomized factorial trial assessing early captopril, oral mononitrate, and intravenous magnesum sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
13. GISSI-3 Investigators. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on the 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-22.
14. Jugdutt BI, Wamica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Circulation 1988;78:906-19.
15. Jugdutt BI. Effects of nitrate therapy on ventricular remodelling and function. Am J Cardiol 1993;72:161G-168G.
16. Jugdutt BI. Prevention of ventricular remodeling postmyocardial infarction. Timing and duration of therapy. Can J Cardiol 1993;9:103-14.
17. Carstensen S, Bonarjee VV, Berning J, Edner M, Nilsen DW, Caidahl K. Effects of early enalapril treatment on global and regional wall motion in acute myocardial infarction. CONSENSUS II Multi Echo Study Group. Am Heart J 1995;129:1101-8.
18. Darius H, Buerke M, Lindemann S, Horstick G, Meyer J. Mechanism of reperfusion damage after thrombolysis and direct PTCA. Fibrinolysis Proteolysis 1997;11:117-22.
19. Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomized trials. Lancet 1988;i:1088-92.
20. Thadani U. Oral nitrates: more than symptomatic therapy in coronary artery disease? Cardiovasc Drugs Ther 1997;11:213-8.
21. Cohn JN, Archibald DG, Ziesche S, et al. Effects of vasodilator therapy on mortality in chronic congestive heart failure. Results of a veterans Administration Cooperative Study. N Engl J Med 1986; 314:1547-52.
22. Munzel T, Kurz S, Heitzer T, Harrison DG. New insights into mechanisms underlying nitrate tolerance. Am J Cardiol 1996;77: 24C-30C.
23. DeCaterina R, Gianessi D, Mazzone A, Bernini W. Mechanism for the in vivo antiplatelet effects of isosorbide dinitrate. Eur Heart J 1988;9(suppl. A):45-9.
24. Darius H, Meyer J. Acetylsalicylsaure bei instabiler Angina, nach koronarer Revaskularisation und bei der Prävention kardialer Thrombembolien. Ztschr Kardiol 1992;81:177-84.
25. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336:525-33.